BioengineeringbioRxivPreprint
Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of Diabetes
A. I. d'Aquino, C. L. Maikawa, L. T. Nguyen…·E. A. Appel
This paper develops a hydrogel-based GLP-1 receptor agonist delivery system that provides sustained therapy for up to 42 days in rats, improving diabetes management compared to daily injections.
DOI 10.1101/2023.01.28.526057